Johnson Investment Counsel’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$682K Sell
9,756
-151
-2% -$10.6K 0.01% 476
2025
Q1
$728K Buy
9,907
+414
+4% +$30.4K 0.01% 453
2024
Q4
$622K Buy
9,493
+2,832
+43% +$186K 0.01% 481
2024
Q3
$519K Sell
6,661
-483
-7% -$37.6K 0.01% 511
2024
Q2
$557K Buy
7,144
+709
+11% +$55.3K 0.01% 475
2024
Q1
$436K Sell
6,435
-48
-0.7% -$3.25K ﹤0.01% 530
2023
Q4
$437K Buy
6,483
+798
+14% +$53.7K 0.01% 507
2023
Q3
$385K Buy
5,685
+668
+13% +$45.2K 0.01% 509
2023
Q2
$359K Buy
5,017
+265
+6% +$19K ﹤0.01% 534
2023
Q1
$330K Sell
4,752
-292
-6% -$20.3K ﹤0.01% 534
2022
Q4
$342K Buy
5,044
+52
+1% +$3.53K ﹤0.01% 523
2022
Q3
$274K Sell
4,992
-58
-1% -$3.18K ﹤0.01% 550
2022
Q2
$334K Sell
5,050
-286
-5% -$18.9K ﹤0.01% 526
2022
Q1
$354K Sell
5,336
-955
-15% -$63.4K ﹤0.01% 540
2021
Q4
$366K Sell
6,291
-994
-14% -$57.8K ﹤0.01% 524
2021
Q3
$438K Buy
7,285
+1,207
+20% +$72.6K 0.01% 475
2021
Q2
$364K Sell
6,078
-672
-10% -$40.2K 0.01% 498
2021
Q1
$336K Sell
6,750
-1,618
-19% -$80.5K 0.01% 489
2020
Q4
$418K Buy
8,368
+1,380
+20% +$68.9K 0.01% 432
2020
Q3
$383K Buy
6,988
+92
+1% +$5.04K 0.01% 424
2020
Q2
$365K Sell
6,896
-1,160
-14% -$61.4K 0.01% 440
2020
Q1
$360K Buy
8,056
+257
+3% +$11.5K 0.01% 420
2019
Q4
$389K Buy
7,799
+660
+9% +$32.9K 0.01% 459
2019
Q3
$318K Buy
+7,139
New +$318K 0.01% 486
2016
Q1
Sell
-6,468
Closed -$219K 549
2015
Q4
$219K Sell
6,468
-1,298
-17% -$43.9K 0.01% 490
2015
Q3
$247K Buy
7,766
+982
+14% +$31.2K 0.01% 473
2015
Q2
$216K Sell
6,784
-2,502
-27% -$79.7K 0.01% 504
2015
Q1
$317K Buy
9,286
+508
+6% +$17.3K 0.01% 432
2014
Q4
$308K Buy
8,778
+102
+1% +$3.58K 0.01% 451
2014
Q3
$309K Hold
8,676
0.01% 430
2014
Q2
$322K Sell
8,676
-3,112
-26% -$115K 0.01% 392
2014
Q1
$382K Sell
11,788
-6
-0.1% -$194 0.01% 338
2013
Q4
$350K Buy
11,794
+272
+2% +$8.07K 0.01% 364
2013
Q3
$299K Buy
11,522
+360
+3% +$9.34K 0.01% 394
2013
Q2
$263K Buy
+11,162
New +$263K 0.01% 423